Edition:
United States

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

10.70USD
14 Dec 2017
Change (% chg)

$-0.35 (-3.17%)
Prev Close
$11.05
Open
$11.00
Day's High
$11.15
Day's Low
$10.60
Volume
110,224
Avg. Vol
239,589
52-wk High
$25.40
52-wk Low
$8.68

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.02 December 15 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 2 2
(2) OUTPERFORM 7 7 7 5
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.08 2.08 2.18 2.22

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 9 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 6 0.00 0.00 0.00 --
Year Ending Dec-17 11 0.72 1.00 0.68 1.25
Year Ending Dec-18 9 0.61 5.50 0.00 12.25
Earnings (per share)
Quarter Ending Dec-17 9 -1.02 -0.85 -1.54 -1.09
Quarter Ending Mar-18 6 -1.03 -0.89 -1.43 --
Year Ending Dec-17 11 -5.19 -4.50 -5.94 -3.77
Year Ending Dec-18 12 -3.60 -2.43 -5.42 -3.38

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.68 0.68 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-17 0.72 0.72 0.72 0.72 1.25
Year Ending Dec-18 0.61 0.61 0.61 0.69 12.25

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings